The Cytology and HPV Testing market is mainly driven by the advent of highly sensitive & specific assays as well as advanced analyzing instruments for cervical cancer screening. Also, the high incidence rate of high-risk types of HPV coupled with the weakening immune system of the population augment the market growth in the coming years. In addition to this, rising awareness along with technological advancements in healthcare are promoting people to opt for high accuracy diagnostic tests, thus bolstering the industry growth during the assessment period.
Category
Country
